FMS Stock Ownership Activity
FRESENIUS MEDICAL CARE-ADR 13F holders
No value investing guru has made any change to the FRESENIUS MEDICAL CARE-ADR (FMS) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying FMS now?
According to the latest SEC filing(s) FRESENIUS MEDICAL CARE-ADR (FMS) has not been purchased by any super investor.
To see more about who is investing in FRESENIUS MEDICAL CARE-ADR (FMS), please go to the FMS ownership page.
2023 Q3
(1 result)
Current price: $22.71
5.10%
Reported price*: $23.93
2023 Q2
(1 result)
Current price: $22.71
5.10%
Reported price*: $23.93
2023 Q1
(1 result)
Current price: $22.71
6.82%
Reported price*: $21.26
2022 Q4
(1 result)
Current price: $22.71
38.98%
Reported price*: $16.34
2022 Q3
(1 result)
Current price: $22.71
61.75%
Reported price*: $14.04
2022 Q2
(1 result)
Current price: $22.71
8.94%
Reported price*: $24.94
2022 Q1
(1 result)
Current price: $22.71
32.57%
Reported price*: $33.68
2021 Q4
(1 result)
Current price: $22.71
30.04%
Reported price*: $32.46
2021 Q3
(1 result)
Current price: $22.71
35.06%
Reported price*: $34.97
2021 Q2
(1 result)
Current price: $22.71
45.37%
Reported price*: $41.57
2021 Q1
(1 result)
Current price: $22.71
38.42%
Reported price*: $36.88
11 of 11
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.